TEL AVIV, Israel, March 07, 2017 -- Alcobra Ltd. (NasdaqGM:ADHD), an emerging pharmaceutical company focused on the development of new medications to treat central nervous system and cognitive disorders, today announced that management will participate in two upcoming investor healthcare conferences during March.
29th Annual ROTH Conference
Date: Tuesday, March 14
Time: 4:00 PM PDT
Location: Ritz Carlton Laguna Niguel, Orange County, CA
Oppenheimer 27th Annual Healthcare Conference
Date: Wednesday, March 22
Time: 9:45 AM EDT
Location: Westin Grand Central, New York, NY
About Alcobra
Alcobra Ltd. is an emerging pharmaceutical company primarily focused on the development and commercialization of medications to treat CNS and cognitive disorders. For more information, please visit the company's website, www.alcobra-pharma.com, the content of which is not incorporated herein by reference.
Investor Contacts Alcobra Investor Relations Debbie Kaye US: 212-390-8964, Intl: +972-3-7299871 IR@alcobra-pharma.com
